Cargando...
Insulin degludec/liraglutide (IDegLira) for the treatment of type 2 diabetes
The progressive nature of type 2 diabetes necessitates that treatment is intensified as the disease advances. Several studies have shown that basal insulin and glucagon-like peptide-1 receptor agonists (GLP-1RAs) can be used in combination to successfully improve glycemic control and this combinatio...
Gardado en:
| Publicado en: | Expert Rev Endocrinol Metab |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4894076/ https://ncbi.nlm.nih.gov/pubmed/27335581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/17446651.2016.1113129 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|